Trials / Completed
CompletedNCT00392067
LEO19123 Cream in the Treatment of Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- LEO Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To compare the efficacy and safety of two different dose combinations of LEO19123 (calcipotriol and LEO80122) with LEO19123 cream vehicle for 3 weeks in the treatment of patients with atopic dermatitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcipotriol and LEO80122 (LEO19123 cream) |
Timeline
- Start date
- 2006-10-01
- Completion
- 2007-06-01
- First posted
- 2006-10-25
- Last updated
- 2025-02-24
Locations
4 sites across 4 countries: Canada, Denmark, Finland, United Kingdom
Source: ClinicalTrials.gov record NCT00392067. Inclusion in this directory is not an endorsement.